FedEx (FDX)

Total Costs & Expenses

$88.34B

TTM · Period ending: · USD

FDX logo

FDX Total Costs & Expenses

Latest reported$88.34B
FDX TTM Total Costs & Expenses (-$2.39B → $88.34B)
High-resolution chart · PNG

FDX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

FedEx Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
88,340,000,000
85,655,000,000
83,959,000,000
82,457,000,000
81,882,000,000
81,771,000,000
81,463,000,000
81,618,000,000
81,338,000,000
81,379,000,000
81,999,000,000
82,857,000,000
84,765,000,000
87,104,000,000
88,282,000,000
88,513,000,000
87,023,000,000
85,119,000,000
83,386,000,000
80,603,000,000
77,825,000,000
73,741,000,000
70,371,000,000
68,025,000,000
66,365,000,000
66,026,000,000
65,045,000,000
64,997,000,000
64,907,000,000
64,338,000,000
63,911,000,000
62,306,000,000
60,505,000,000
58,861,000,000
57,087,000,000
55,742,000,000
54,893,000,000
53,978,000,000
51,874,000,000
49,484,000,000
47,288,000,000
47,400,000,000
46,364,000,000
45,974,000,000
45,536,000,000
43,033,000,000
42,939,000,000
42,589,000,000
42,121,000,000
41,802,000,000
41,459,000,000
41,272,000,000
41,093,000,000
39,370,000,000
38,804,000,000
38,222,000,000
37,956,000,000
39,005,000,000
37,171,000,000
35,204,000,000
33,047,000,000
30,829,000,000
30,011,000,000
29,010,000,000
27,954,000,000
26,808,000,000
26,446,000,000
27,021,000,000
29,173,000,000
23,501,000,000
26,790,000,000
29,266,000,000
30,114,000,000
38,808,000,000
37,929,000,000
37,294,000,000
36,624,000,000
35,998,000,000
35,295,000,000
34,508,000,000
33,332,000,000
32,160,000,000
31,103,000,000
29,897,000,000
29,217,000,000
28,751,000,000
27,598,000,000
26,344,000,000
25,190,000,000
23,988,000,000
23,582,000,000
23,408,000,000
23,273,000,000
22,999,000,000
22,600,000,000
22,245,000,000
21,865,000,000
21,768,623,000
21,520,330,000
21,092,360,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.